USPTO Refuses Again To Reissue Lipitor Patent
The U.S. Patent and Trademark Office has again rebuffed Pfizer Inc.'s bid to reissue one of the patents behind its blockbuster cholesterol drug Lipitor....To view the full article, register now.
Already a subscriber? Click here to view full article